Increased fatty acid synthase is a therapeutic target in mesothelioma.


Many common human cancer tissues express high levels of fatty acid synthase (FAS), the primary enzyme for the synthesis of fatty acids, and the differential expression of FAS between normal and neoplastic tissues has led to the consideration of FAS as a target for anticancer therapy. To investigate the potential of targeting FAS for the treatment of pleural… (More)


4 Figures and Tables

Slides referencing similar topics